Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder (2011)
- Authors:
- USP affiliated authors: MIGUEL FILHO, EURIPEDES CONSTANTINO - FM ; FOSSALUZA, VICTOR - IME
- Unidades: FM; IME
- DOI: 10.1590/S1807-59322011000300004
- Subjects: FATORES DE RISCO; TRANSTORNO OBSESSIVO-COMPULSIVO (TERAPIA); TRANSTORNOS DA ANSIEDADE; TRANSTORNOS SOMATOFORMES
- Language: Inglês
- Imprenta:
- Source:
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
DINIZ, Juliana Belo et al. Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder. Clinics, v. 66, n. 3, p. 387-393, 2011Tradução . . Disponível em: https://doi.org/10.1590/S1807-59322011000300004. Acesso em: 31 mar. 2026. -
APA
Diniz, J. B., Malavazzi, D. M., Fossaluza, V., Belotto-Silva, C., Borcato, S., Pimentel, I., et al. (2011). Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder. Clinics, 66( 3), 387-393. doi:10.1590/S1807-59322011000300004 -
NLM
Diniz JB, Malavazzi DM, Fossaluza V, Belotto-Silva C, Borcato S, Pimentel I, Miguel EC, Shavitt RG. Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder [Internet]. Clinics. 2011 ; 66( 3): 387-393.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1590/S1807-59322011000300004 -
Vancouver
Diniz JB, Malavazzi DM, Fossaluza V, Belotto-Silva C, Borcato S, Pimentel I, Miguel EC, Shavitt RG. Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder [Internet]. Clinics. 2011 ; 66( 3): 387-393.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1590/S1807-59322011000300004 - Does anti-obsessional pharmacotherapy treat so-called comorbid depressive and anxiety states?
- Perinatal risk factors and obsessive-compulsive spectrum disorders in patients with rheumatic fever
- Group cognitive-behavioral therapy versus selective serotonin reuptake inhibitors for obsessive-compulsive disorder: A practical clinical trial
- Comorbid major depression in obsessive-compulsive disorder patients
- Higher prevalence of obsessive-compulsive and related disorders in rheumatic fever
- Obsessive-compulsive disorder: Influence of age at onset on comorbidity patterns
- A double-blind, randomized, controlled trial of fluoxetine plus Quetiapine or Clomipramine versus Fluoxetine Plus Placebo for obsessive-compulsive disorder
- Higher prevalence of obsessive-compulsive spectrum disorders in rheumatic fever
- A double-blind randomized controlled trial of fluoxetine plus quetiapine or clomipramine vs. Fluoxetine plus placebo for obsessive-compulsive disorder
- Trajectory in obsessive-compulsive disorder comorbidities
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
